Inventor · disambiguated record
Xiaoxia Liu
Also filed as: LIU XIAOXIA
33 granted patents·4 pending applications·102 citations·filing 2002–2019
96Inventor score
Top patents by PatentIndex Score
37 records- 0190US8791161B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Jul 29, 2014·7 cites·14 claims
- 0289US8927544B2Benzofuran-2-sulfonamides derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Jan 6, 2015·4 cites·6 claims
- 0387US8450367B2Sulfur derivatives as chemokine receptor modulatorsYUAN HAIQING·Filed 2011·Granted May 28, 2013·7 cites·16 claims
- 0487US7737173B2Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activityALLERGAN INC·Filed 2007·Granted Jun 15, 2010·6 cites·3 claims
- 0586US8815915B2Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Aug 26, 2014·3 cites·12 claims
- 0685US7728014B2Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activityALLERGAN INC·Filed 2007·Granted Jun 1, 2010·4 cites·7 claims
- 0784US8822530B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Sep 2, 2014·3 cites·14 claims
- 0883US8877804B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Nov 4, 2014·3 cites·2 claims
- 0982US7476673B2Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptorsALLERGAN INC·Filed 2004·Granted Jan 13, 2009·20 cites·38 claims
- 1081US9371278B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Granted Jun 21, 2016·2 cites·13 claims
- 1181US9328067B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted May 3, 2016·2 cites·7 claims
- 1281US8518913B2Phosphorous derivatives as chemokine receptor modulatorsYUAN HAIQING·Filed 2011·Granted Aug 27, 2013·3 cites·14 claims
- 1381US7226951B2Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the sameALLERGAN INC·Filed 2004·Granted Jun 5, 2007·13 cites·4 claims
- 1480US8580779B21,2-bis-sulfonamide derivatives as chemokine receptor modulatorsYUAN HAIQING·Filed 2011·Granted Nov 12, 2013·4 cites·5 claims
- 1578US11046644B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2019·Granted Jun 29, 2021·0 cites·6 claims
- 1678US9416120B2Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Granted Aug 16, 2016·1 cites·8 claims
- 1777US10287243B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2015·Granted May 14, 2019·1 cites·9 claims
- 1877US9663460B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Granted May 30, 2017·1 cites·13 claims
- 1977US8524917B26-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activityBEARD RICHARD L·Filed 2008·Granted Sep 3, 2013·2 cites·14 claims
- 2074US8524745B2Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2012·Granted Sep 3, 2013·2 cites·14 claims
- 2171US7468391B2Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26BALLERGAN INC·Filed 2004·Granted Dec 23, 2008·5 cites·12 claims
- 2270US6740676B24-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome p450rai inhibitory activityALLERGAN INC·Filed 2002·Granted May 25, 2004·5 cites·32 claims
- 2368US6683092B1[3-(c5-14alkyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-3-oxo-propenyl]-phenyl and [3-(c5-14alkyl-2-oxo-1,2,3,4- tetrahydro-quinolin-6-yl)-3-oxo-propenyl]-heteroaryl derivatives having anti-tumor activityALLERGAN INC·Filed 2003·Granted Jan 27, 2004·4 cites·31 claims
- 2462US8729066B21,2- bis-sulfonamide derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted May 20, 2014·0 cites·11 claims
- 2562US2014221351A1Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 2660US9550746B2Benzofuran-2-sulfonamides derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2015·Granted Jan 24, 2017·0 cites·4 claims
- 2758US7432388B2Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activityALLERGAN INC·Filed 2007·Granted Oct 7, 2008·0 cites·4 claims
- 2856US7638648B2Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the sameALLERGAN INC·Filed 2007·Granted Dec 29, 2009·0 cites·10 claims
- 2954US9603834B21,2- bis-sulfonamide derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2015·Granted Mar 28, 2017·0 cites·11 claims
- 3054US7253319B2Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activityALLERGAN INC·Filed 2004·Granted Aug 7, 2007·0 cites·18 claims
- 3153US7351737B24-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activityALLERGAN INC·Filed 2003·Granted Apr 1, 2008·0 cites·38 claims
- 3251US2013338158A16-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activityALLERGAN INC·Filed 2013·Application pending·0 cites
- 3350US9670190B2Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Granted Jun 6, 2017·0 cites·13 claims
- 3447US2015152080A1Benzothiophene sulfonamides derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 3542US8513220B2Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activityTAKEUCHI JANET A·Filed 2012·Granted Aug 20, 2013·0 cites·8 claims
- 3642US6887896B17-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activityALLERGAN INC·Filed 2003·Granted May 3, 2005·0 cites·68 claims
- 3738US2011281822A1Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activityTAKEUCHI JANET A·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaoxia Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →